The human side of microglia

AM Smith, M Dragunow - Trends in neurosciences, 2014 - cell.com
Despite increasing evidence of major differences between rodent and human immune and
neurological function, relatively few biomedical studies are performed with human cells. This …

Astrocyte differentiation of human pluripotent stem cells: new tools for neurological disorder research

A Chandrasekaran, HX Avci, M Leist… - Frontiers in cellular …, 2016 - frontiersin.org
Astrocytes have a central role in brain development and function, and so have gained
increasing attention over the past two decades. Consequently, our knowledge about their …

Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells

P Douvaras, J Wang, M Zimmer, S Hanchuk… - Stem cell reports, 2014 - cell.com
Multiple sclerosis (MS) is a chronic demyelinating disease of unknown etiology that affects
the CNS. While current therapies are primarily directed against the immune system, the new …

Neural stem cell transplantation in central nervous system disorders: from cell replacement to neuroprotection

D De Feo, A Merlini, C Laterza… - Current opinion in …, 2012 - journals.lww.com
Nowadays, the research on NPC transplantation in neurological disorders is advancing on
two different fronts: on one hand, recent preclinical data are uncovering the molecular basis …

Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells

AE Mungenast, S Siegert, LH Tsai - Molecular and Cellular Neuroscience, 2016 - Elsevier
In the last decade, induced pluripotent stem (iPS) cells have revolutionized the utility of
human in vitro models of neurological disease. The iPS-derived and differentiated cells …

Stem cell therapy for multiple sclerosis

B Genc, HR Bozan, S Genc, K Genc - Tissue Engineering and …, 2019 - Springer
Multiple sclerosis (MS) is a chronic inflammatory, autoimmune, and neurodegenerative
disease of the central nervous system (CNS). It is characterized by demyelination and …

[HTML][HTML] Shh and Olig2 sequentially regulate oligodendrocyte differentiation from hiPSCs for the treatment of ischemic stroke

J Xu, J Zhao, R Wang, Y Zhang, L Shen, Q Xiao… - Theranostics, 2022 - ncbi.nlm.nih.gov
Rationale: Demyelination is a major component of white matter injury, characterized by
oligodendrocyte (OL) death and myelin sheath loss, which result in memory loss and …

The behavior of cardiac progenitor cells on macroporous pericardium-derived scaffolds

S Rajabi-Zeleti, S Jalili-Firoozinezhad, M Azarnia… - Biomaterials, 2014 - Elsevier
Cardiovascular diseases hold the highest mortality rate among other illnesses which reveals
the significance of current limitations in common therapies. Three-dimensional (3D) …

In vitro myelin formation using embryonic stem cells

BE Kerman, HJ Kim, K Padmanabhan, A Mei… - …, 2015 - journals.biologists.com
Myelination in the central nervous system is the process by which oligodendrocytes form
myelin sheaths around the axons of neurons. Myelination enables neurons to transmit …

Stem cell derived oligodendrocytes to study myelin diseases

K Chanoumidou, S Mozafari, A Baron‐van Evercooren… - Glia, 2020 - Wiley Online Library
Oligodendroglial pathology is central to de‐and dysmyelinating, but also contributes to
neurodegenerative and psychiatric diseases as well as brain injury. The understanding of …